Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
Advances in therapy
View this publicationAdvances in therapy
View this publicationJournal of critical care
View this publicationiScience
View this publicationCancer research
View this publicationFrontiers in medicine
View this publicationNature medicine
View this publicationNature reviews. Cardiology
View this publicationThe Lancet regional health. Europe
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publicationCell host & microbe
View this publication